Clin Mol Hepatol.
2022 Jan;28(1):47-49. 10.3350/cmh.2021.0338.
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- 3Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea
- KMID: 2523869
- DOI: http://doi.org/10.3350/cmh.2021.0338
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
- The Diagnosis of Nonalcoholic Fatty Liver Disease
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
- Nonalcoholic fatty liver disease: pathogenesis and treatment
